OCTOBIDPublic Tender GazetteNEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
Grant monitored from grants-gov.
- Buyer / agency
- National Institutes of Health
- Notice type
- Grant
- Solicitation number
- PAR-28-072
- Posted
- September 25, 2026
- Response deadline
- November 16, 2029
- Location
- US
- Estimated value
- Not published by the source
- NAICS
- Not supplied
- Source
- grants-gov
Summary
The purpose of NEI's Translational Research program (TRP) is the rapid and efficient translation of innovative laboratory research findings into therapeutics for use by clinicians to treat visual system diseases or disorders. The TRP will support the product development of biological, pharmaceutical, medical device, and/or combination therapies for any disease or disorder of the visual system.The TRP will utilize a bi-phasic, milestone-driven mechanism of award. The R61 phase…
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.